ATR inhibition enables complete tumour regression in ALK-driven NB mouse models von Szydzik, Joanna, Lind, Dan E., Arefin, Badrul, Kurhe, Yeshwant, Umapathy, Ganesh, Siaw, Joachim Tetteh, Claeys, Arne, Gabre, Jonatan L., Van den Eynden, Jimmy, Hallberg, Bengt, Palmer, Ruth H.

Volltext

Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate von Romiani, Arman, Spetz, Johan, Shubbar, Emman, Lind, Dan E., Hallberg, Bengt, Palmer, Ruth H., Forssell-Aronsson, Eva

Volltext

Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth von Lai, Wei-Yun, Chuang, Tzu-Po, Borenäs, Marcus, Lind, Dan E., Hallberg, Bengt, Palmer, Ruth H.

Volltext

Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells von Alam, Muhammad Wasi, Borenäs, Marcus, Lind, Dan E, Cervantes-Madrid, Diana, Umapathy, Ganesh, Palmer, Ruth H, Hallberg, Bengt

Volltext

ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation von Borenäs, Marcus, Umapathy, Ganesh, Lai, Wei‐Yun, Lind, Dan E, Witek, Barbara, Guan, Jikui, Mendoza‐Garcia, Patricia, Masudi, Tafheem, Claeys, Arne, Chuang, Tzu‐Po, El Wakil, Abeer, Arefin, Badrul, Fransson, Susanne, Koster, Jan, Johansson, Mathias, Gaarder, Jennie, Van den Eynden, Jimmy, Hallberg, Bengt, Palmer, Ruth H

Volltext

ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression von Chuang, Tzu-Po, Lai, Wei-Yun, Gabre, Jonatan L, Lind, Dan E, Umapathy, Ganesh, Bokhari, Abdulmalik A, Bergman, Bengt, Kristenson, Linnea, Thorén, Fredrik B, Le, Anh, Doebele, Robert C, Van den Eynden, Jimmy, Palmer, Ruth H, Hallberg, Bengt

Volltext

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition von Borenäs, Marcus, Umapathy, Ganesh, Lind, Dan E, Lai, Wei-Yun, Guan, Jikui, Johansson, Joel, Jennische, Eva, Schmidt, Alexander, Kurhe, Yeshwant, Gabre, Jonatan L, Aniszewska, Agata, Strömberg, Anneli, Bemark, Mats, Hall, Michael N, Eynden, Jimmy Van den, Hallberg, Bengt, Palmer, Ruth H

Volltext

Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice von Caputo, Mara, Andersson, Emma, Xia, Ying, Hou, Wei, Cansby, Emmelie, Erikson, Max, Lind, Dan Emil, Hallberg, Bengt, Amrutkar, Manoj, Mahlapuu, Margit

Volltext

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition von Borenäs, Marcus, Umapathy, Ganesh, Lind, Dan E, Lai, Wei-Yun, Guan, Jikui, Johansson, Joel, Jennische, Eva, Schmidt, Alexander, Kurhe, Yeshwant, Gabre, Jonatan Linus, Aniszewska, Agata, Strömberg, Anneli, Bemark, Mats, Hall, Michael N, Van den Eynden, Jimmy, Hallberg, Bengt, Palmer, Ruth H

Volltext

ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression von Chuang, Tzu-Po, Lai, Wei-Yun, Gabre, Jonatan Linus, Lind, Dan E, Umapathy, Ganesh, Bokhari, Abdulmalik A, Bergman, Bengt, Kristenson, Linnea, Thorén, Fredrik B, Le, Anh, Doebele, Robert C, Van den Eynden, Jimmy, Palmer, Ruth H, Hallberg, Bengt

Volltext

Neuroblastoma xenograft models demonstrate the therapeutic potential of Lu-177-octreotate von Romiani, Arman, Spetz, Johan, Shubbar, Emman, Lind, Dan E., Hallberg, Bengt, Palmer, Ruth H., Forssell-Aronsson, Eva

Volltext

ATR inhibition enables complete tumour regression in ALK-driven NB mouse models von Szydzik, Joanna, Lind, Dan E, Arefin, Badrul, Kurhe, Yeshwant, Umapathy, Ganesh, Siaw, Joachim Tetteh, Claeys, Arne, Gabre, Jonatan Linus, Van den Eynden, Jimmy, Hallberg, Bengt, Palmer, Ruth H

Volltext

Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice von Romiani, A., Simonsson, K., Pettersson, D., Al-Awar, A., Rassol, N., Bakr, H., Lind, D.E., Umapathy, G., Spetz, J., Palmer, R.H., Hallberg, B., Helou, K., Forssell-Aronsson, E.

Volltext

Synergistic Antitumor Effects of 177Lu-Octreotide Combined with an ALK Inhibitor in a High-Risk Neuroblastoma Xenograft Model von Romiani, Arman, Pettersson, Daniella, Rassol, Nishte, Simonsson, Klara, Bakr, Hana, Lind, Dan E., Kovács, Anikó, Spetz, Johan, Palmer, Ruth H., Hallberg, Bengt, Helou, Khalil, Forssell-Aronsson, Eva

Volltext

ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation von Borenäs, Marcus, Umapathy, Ganesh, Lai, Wei‐Yun, Lind, Dan E, Witek, Barbara, Guan, Jikui, Mendoza‐Garcia, Patricia, Masudi, Tafheem, Claeys, Arne, Chuang, Tzu‐Po, El Wakil, Abeer, Arefin, Badrul, Fransson, Susanne, Koster, Jan, Johansson, Mathias, Gaarder, Jennie, Van den Eynden, Jimmy, Hallberg, Bengt, Palmer, Ruth H

Volltext

Synergistic antitumor effects of Lorlatinib and 177Lu-octreotide combination treatment in a high-risk neuroblastoma xenograft mouse model von Romiani, Arman, Pettersson, Daniella, Simonsson, Klara, Bakr, Hana, Lind, Dan E., Kovács, Anikó, Spetz, Johan, Palmer, Ruth H., Hallberg, Bengt, Helou, Khalil, Forssell-Aronsson, Eva

Volltext

Abstract C159: ALK signaling primes the DNA damage response allowing exploitation of ATR inhibition in ALK-driven Neuroblastoma von Borenäs, Marcus, Umapathy, Ganesh, Lind, Dan E., Lai, Wei-Yun, Guan, Jikui, Johansson, Joel, Jennische, Eva, Schmidt, Alexander, Gabre, Jonatan, Bemark, Mats, Hall, Michael N., Eynden, Jimmy Van den, Hallberg, Bengt, Palmer, Ruth H.

Volltext

Abstract 3936: ALK fusion oncogene driven SERPINB4 expression enhances tumor survival in NSCLC von Chuang, Tzu-Po, Lai, Wei-Yun, Gabre, Jonatan L., Lind, Dan E., Umapathy, Ganesh, Bokhari, Abdulmalik A., Bergman, Bengt, Kristenson, Linnea, Thorén, Fredrik B., Le, Anh, Doebele, Robert, Eynden, Jimmy V., Palmer, Ruth H., Hallberg, Bengt

Volltext

Oxygen Targets in Comatose Survivors of Cardiac Arrest von Schmidt, Henrik, Kjaergaard, Jesper, Hassager, Christian, Mølstrøm, Simon, Grand, Johannes, Borregaard, Britt, Roelsgaard Obling, Laust E., Venø, Søren, Sarkisian, Laura, Mamaev, Dmitry, Jensen, Lisette O., Nyholm, Benjamin, Høfsten, Dan E., Josiassen, Jakob, Thomsen, Jakob H., Thune, Jens J., Lindholm, Matias G., Stengaard Meyer, Martin A., Winther-Jensen, Matilde, Sørensen, Marc, Frydland, Martin, Beske, Rasmus P., Frikke-Schmidt, Ruth, Wiberg, Sebastian, Boesgaard, Søren, Lind Jørgensen, Vibeke, Møller, Jacob E.

Volltext

Duration of Device-Based Fever Prevention after Cardiac Arrest von Hassager, Christian, Schmidt, Henrik, Møller, Jacob E., Grand, Johannes, Mølstrøm, Simon, Beske, Rasmus P., Boesgaard, Søren, Borregaard, Britt, Bekker-Jensen, Ditte, Dahl, Jordi S., Frydland, Martin S., Høfsten, Dan E., Isse, Yusuf A., Josiassen, Jakob, Lind Jørgensen, Vibeke R., Kondziella, Daniel, Lindholm, Matias G., Moser, Emil, Nyholm, Benjamin C., Obling, Laust E.R., Sarkisian, Laura, Søndergaard, Frederik T., Thomsen, Jakob H., Thune, Jens J., Venø, Søren, Wiberg, Sebastian C., Winther-Jensen, Matilde, Meyer, Martin A.S., Kjaergaard, Jesper

Volltext